Table 2.
Types of subcellular targeted drug delivery systems.
| S.No. | Target | Drug/Formulation | Mechanism | Disease | Ref. |
|---|---|---|---|---|---|
| 1. | Plasma membrane | Enfuvirtide C34 | Membrane targeted inhibition of HIV fusion complex | AIDS-HIV | (Rajendran et al., 2010) |
| 2. | Nuclear targeting | RGD peptide systems | regression in αvβ3-overexpressing cancer | Human breast cancer and melanoma | (Park et al., 2016; Nurunnabi et al., 2019) |
| 3. | Nuclear targeting | Cell penetrating TAT peptides | enhancing cytoplasmic delivery, transfection efficiency | Liver cancer | (Richard et al., 2003; Song et al., 2010; Nurunnabi et al., 2019) |
| 4. | Nuclear targeting | Viral like particles/liposomes | Targeted gene delivery by viral-mediated vectors | Carcinoma | (Nayerossadat et al., 2012; Leucuta, 2014; Sung and Kim, 2019) |
| 5. | Endosomes (early) | Cholesterol conjugated β-secretase inhibitors | Membrane attachment followed by endocytosis into endosomes | Alzheimer's disease | (Cheng et al., 2007; Cole and Vassar, 2007) |
| 6. | Mitochondria | Paclitaxel liposomes | Better cellular uptake and accumulation in mitochondria and enhanced cytotoxicity | Liver cancer | (Biswas et al., 2011; Wang et al., 2017) |
| 7. | Mitochondria | Curcumin DQAsomes | Appreciable antioxidant and anti-inflammatory efficacy | Acute lung injury | (Zupančič et al., 2014) |
| 8. | Mitochondria | Doxorubicin Cerasomes | greater drug accumulation in mitochondria and greater antitumor effect | Targeted Tumor therapy | (Wang et al., 2015) |
| 9. | Mitochondria | Coenzyme Q10 Micelles | Enhanced cellular uptake and higher mitochondrial accumulation | oxidative stress and inflammation | (Sharma et al., 2012) |
| 10. | Mitochondria | α-tocopheryl succinate Mesoporous Silica NPs | Intracellular uptake and mitochondrial accumulation | Anticancer therapy | (Qu et al., 2016) |
| 11. | Golgi Bodies and ER | Conjugated Antigenic peptide | Targeted presentation on MHC class I complex by conjugation to STX-B | Ovarian cancer, intestinal cancer and lymphomas | (Morse et al., 2011; Reeves and James, 2017) |
| 12. | Golgi Bodies and ER | Rhodamine-loaded PLGA (polylactic-co-glycolic acid) NPs | colocalization with early endosomes, late endosomes, lysosomes, endoplasmic reticulum (ER), and Golgi apparatus | Respiratory, gut and renal targeted delivery | (Cartiera et al., 2009) |
| 13. | Cell membrane (receptors) | Transferrin eight arm polyethylene glycol-dihydroartemisinine nanoparticles | Transferrin receptors mediated cellular internalization | Lewis Lung carcinoma | (Liu et al., 2016; Liu et al., 2017) |
| 14. | Cell membrane (receptors) | Adenosine conjugated Solid Lipid Nanoparticles | G-protein coupled receptors mediated cellular internalization | Human cancer | (Swami et al., 2015; Ma et al., 2018) |
| 15. | Epidermal Growth Factor Receptors | GE11 peptide conjugated Exosomes for microRNA | efficient delivery of microRNA (miRNA) to epidermal growth factor receptor (EGFR)-expressing breast cancer cells | Breast cancer | (Li et al., 2005; Ohno et al., 2013) |